重症疾病后高CRP水平与再住院风险增加相关
这项前瞻性观察研究纳入66例存活至出院的危重症患者,在出院时及出院后1、2、6周测定CRP,并随访1.5年筛查再住院或死亡等不良事件。出院后超过三分之二患者CRP升高(>2.0 mg/L);第一周CRP较出院时下降(P < 0.001),第1周后不再变化(P = 0.67)。年龄(P = 0.24)、手术状态(P = 0.95)或脓毒症(P = 0.77)不影响CRP变化轨迹;有无不良事件两组(15例 vs 51例)的CRP轨迹不同(P = 0.003)。无不良事件者出院后CRP持续下降(P = 0.03),有不良事件者未下降(P = 0.86)但早期反弹。
要点
- 66例存活出院危重症患者中,出院后超过三分之二CRP升高(>2.0 mg/L),提示慢性亚临床炎症。
- 出院后第一周CRP较出院时下降(P < 0.001),第1周后至第6周不再变化(P = 0.67)。
- 年龄(P = 0.24)、手术状态(P = 0.95)、脓毒症(P = 0.77)不影响CRP变化轨迹。
- 有无不良事件两组(15例 vs 51例)CRP轨迹不同(P = 0.003):无不良事件者CRP持续下降(P = 0.03),有不良事件者未下降(P = 0.86)但早期反弹。
- 出院后CRP持续升高与再住院风险增加相关。
适用人群与场景
- 存活至出院的危重症患者66例,前瞻性观察研究纳入。
- 随访1.5年,重复筛查再住院或死亡等不良事件。
诊断标准与关键阈值
- CRP升高定义为>2.0 mg/L。
- CRP测定时间点:出院时及出院后1、2、6周。
研究设计与关键结果
- 前瞻性观察研究,66例存活至出院的危重症患者,出院后超过三分之二CRP升高(>2.0 mg/L)。
- 出院后第一周CRP较出院时下降(P < 0.001),第1周后不再变化(P = 0.67)。
- 年龄(P = 0.24)、手术状态(P = 0.95)、脓毒症(P = 0.77)不影响CRP变化轨迹。
- 有无不良事件两组(15例 vs 51例)CRP轨迹不同(P = 0.003)。
- 无不良事件者出院后CRP持续下降(P = 0.03),有不良事件者未下降(P = 0.86)但早期反弹。
- 出院后CRP持续升高与再住院风险增加相关。
证据类型、等级与局限
- 证据类型:前瞻性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为出院后CRP持续升高与再住院风险增加相关,提示对重症存活者出院后CRP轨迹的监测可能有助于识别再住院高风险者。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Chronic inflammation, even at subclinical levels, is associated with adverse long-term outcome.
PATIENTS AND METHODS: In this prospective, observational study, 66 critically ill patients surviving to hospital discharge were included. C-reactive protein (CRP) levels were determined at hospital discharge, 1, 2, and 6 weeks after hospital discharge. All the patients were repeatedly screened for adverse events resulting in rehospitalization or death for 1.5 years.
RESULTS: After hospital discharge, over two-thirds of the patients exhibited elevated CRP levels (>2.0 mg/L). During the first week, CRP decreased compared with hospital discharge (P < 0.001) but did not change after week 1 (P = 0.67). Age (P = 0.24), surgical status (P = 0.95), or sepsis (P = 0.77) did not influence the CRP course. The latter differed between patients with (n = 15) and without (n = 51) adverse events (P = 0.003). CRP levels of patients without adverse events persistently decreased after hospital discharge (P = 0.03), whereas those of patients with adverse events did not (P = 0.86) but rebounded early.
CONCLUSIONS: Plasma CRP levels in critically ill patients decreased during the first week after hospital discharge but remained unchanged during the subsequent 5 weeks. Over two-thirds of the patients exhibited elevated CRP levels compatible with chronic sub-clinical inflammation. Persistently elevated CRP levels after hospital discharge are associated with higher risk of rehospitalization.
参考来源
- Grander W, Koller B, Ludwig C, et al. High CRP Levels After Critical Illness are Associated With an Increased Risk of Rehospitalization. Shock. 2018. PMID: 29438222. doi:10.1097/SHK.0000000000001118
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。